Comparison of early and late 68Ga-FAPI-46-PET in 33 patients with possible recurrence of pancreatic ductal adenocarcinomas

被引:2
|
作者
Hoppner, Jorge [1 ]
van Genabith, Levin [1 ]
Hielscher, Thomas [2 ]
Heger, Ulrike [3 ]
Sperling, Lucas [3 ]
Colbatzky, Teresa [3 ]
Gutjahr, Ewgenija [4 ]
Lang, Matthias [3 ]
Pausch, Thomas [3 ]
Spektor, Anna-Maria [1 ]
Glatting, Frederik M. [5 ]
Liermann, Jakob [6 ]
Hackert, Thilo [3 ]
Kratochwil, Clemens [1 ]
Giesel, Frederik L. [1 ,7 ]
Haberkorn, Uwe [1 ,8 ]
Roehrich, Manuel [1 ,9 ]
机构
[1] Univ Hosp Heidelberg, Dept Nucl Med, Im Neuenheimer Feld 400, D-69120 Heidelberg, Germany
[2] German Canc Res Ctr, Dept Biostat, Heidelberg, Germany
[3] Univ Hosp Heidelberg, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany
[4] Univ Hosp Heidelberg, Dept Pathol, Heidelberg, Germany
[5] German Canc Res Ctr, Clin Cooperat Unit Mol Radiat Oncol, Heidelberg, Germany
[6] Univ Hosp Heidelberg, Dept Radiat Oncol, Heidelberg, Germany
[7] Univ Hosp Dusseldorf, Dept Nucl Med, Dusseldorf, Germany
[8] German Canc Res Ctr, Clin Cooperat Unit Nucl Med, Heidelberg, Germany
[9] Univ Hosp Mainz, Dept Nucl Med, Langenbeckstr 1, D-55131 Mainz, Germany
关键词
PET/CT; CANCER;
D O I
10.1038/s41598-023-43049-2
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Positron emission tomography with (68)Gallium (Ga-68) labeled inhibitors of fibroblast activation protein (Ga-68-FAPI-PET) is a promising imaging technique for patients with recurrent pancreatic ductal adenocarcinomas (PDAC). To date, it is not clear if different acquisition timepoints for Ga-68-FAPI-PET may result in comparable imaging information and if repetitive Ga-68-FAPI-PET imaging may add diagnostic value to single timepoint acquisition for recurrent PDAC. Here we analyzed retrospectively early (20 min p.i.) and late (60 min p.i.) Ga-68-FAPI-PET imaging using FAPI-46 of 33 patients with possible recurrence of PDAC concerning detection rates and uptake over time of local recurrences, metastases, inflammatory lesions of the pancreas, cholestatic lesions of the liver and reactive tissue. 33 patients with histologically confirmed PDAC after complete or partial resection of the pancreas and possible recurrence were examined by Ga-68-FAPI-46-PET acquired 20- and 60-min post injection (p.i.) of the radiotracer. FAPI-positive lesions were classified as local recurrences, metastases, inflammatory lesions of the pancreas (ILP), cholestatic lesions of the liver and reactive tissue based on histology, PET- and CT-morphology and clinical information. Lesions were contoured, and standardized uptake values (SUVmax and SUVmean) and target-to-background ratios (TBR) were analyzed for both acquisition timepoints. In total, 152 FAPI-positive lesions (22 local relapses, 47 metastases, 26 inflammatory lesions of the pancreas, 28 reactive tissues, and 29 cholestatic lesions) were detected. Detection rates for the early and late acquisition of Ga-68-FAPI-46-PET were almost identical except cholestatic lesions, which showed a higher detection rate at early imaging. SUV parameters and TBRs of ILP significantly decreased over time. Cholestatic lesions showed a tendency towards decreasing uptake. All other types of lesions showed relatively stable uptake over time. Early and late acquisition of Ga-68-FAPI-PET results in comparable imaging information in patients with possible recurrence of PDAC. Two timepoint imaging offers additional diagnostic potential concerning differential diagnoses.
引用
收藏
页数:11
相关论文
共 37 条
  • [21] Accurate preoperative staging with [68Ga]Ga-FAPI PET/CT for patients with oral squamous cell carcinoma: a comparison to 2-[18F]FDG PET/CT
    Shaoming Chen
    Zhenying Chen
    Gengsen Zou
    Shan Zheng
    Ke Zheng
    Jiaying Zhang
    Chao Huang
    Shaobo Yao
    Weibing Miao
    European Radiology, 2022, 32 : 6070 - 6079
  • [22] Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer
    Haojun Chen
    Yizhen Pang
    Jingxun Wu
    Liang Zhao
    Bing Hao
    Jing Wu
    Jihong Wei
    Siming Wu
    Long Zhao
    Zuoming Luo
    Xuehua Lin
    Chengrong Xie
    Long Sun
    Qin Lin
    Hua Wu
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 1820 - 1832
  • [23] [68Ga]Ga-FAPI PET/CT Improves the T Staging of Patients with Newly Diagnosed Nasopharyngeal Carcinoma: A Comparison with [18F]F-FDG
    Jieling Zheng
    Feng Liu
    KaiXian Lin
    Li Zhang
    Nan Huang
    Wanjing Zheng
    Jiaying Zhang
    Shaobo Yao
    Weibing Miao
    Molecular Imaging and Biology, 2022, 24 : 973 - 985
  • [24] Comparison of 68Ga-FAPI-04 and 18F-FDG PET/CT for diagnosis of metastatic lesions in patients with recurrent papillary thyroid carcinoma
    Sayiner, Zeynel Abidin
    Elboga, Umut
    Sahin, Ertan
    Ozturk, Sadettin
    Cayirli, Yusuf Burak
    Celen, Yusuf Zeki
    Akarsu, Ersin
    Dogan, Ilkay
    Kilbas, Benan
    Eryilmaz, Kurtulus
    Cakici, Davut
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2023, 26 (01) : 41 - 46
  • [25] Comparison of the Relative Diagnostic Performance of [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/CT for the Detection of Bone Metastasis in Patients With Different Cancers
    Wu, Junhao
    Wang, Yingwei
    Liao, Taiping
    Rao, Zijuan
    Gong, Weidong
    Ou, Lei
    Chen, Yue
    Zhang, Chunyin
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [26] Early Injection of Furosemide Increases Detection Rate of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for 68Ga-PSMA-11 PET/CT
    Uprimny, Christian
    Bayerschmidt, Steffen
    Kroiss, Alexander Stephan
    Fritz, Josef
    Nilica, Bernhard
    Svirydenka, Hanna
    Decristoforo, Clemens
    von Guggenberg, Elisabeth
    Horninger, Wolfgang
    Virgolini, Irene Johanna
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (11) : 1550 - 1557
  • [27] Head-to-Head Comparison of 68Ga-FAPI-46 and 18F-FDG PET/CT for Evaluation of Head and Neck Squamous Cell Carcinoma: A Single-Center Exploratory Study
    Promteangtrong, Chetsadaporn
    Siripongsatian, Dheeratama
    Jantarato, Attapon
    Kunawudhi, Anchisa
    Kiatkittikul, Peerapon
    Yaset, Sukanya
    Boonkawin, Natphimol
    Chotipanich, Chanisa
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (08) : 1155 - 1161
  • [28] Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence
    Calais, Jeremie
    Fendler, Wolfgang P.
    Herrmann, Ken
    Eiber, Matthias
    Ceci, Francesco
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (05) : 789 - 794
  • [29] Comparison of Early Imaging and Imaging 60 min Post-Injection after Forced Diuresis with Furosemide in the Assessment of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for 68Ga-PSMA-11 PET/CT
    Bayerschmidt, Steffen
    Uprimny, Christian
    Kroiss, Alexander Stephan
    Fritz, Josef
    Nilica, Bernhard
    Svirydenka, Hanna
    Decristoforo, Clemens
    von Guggenberg, Elisabeth
    Horninger, Wolfgang
    Virgolini, Irene Johanna
    DIAGNOSTICS, 2021, 11 (07)
  • [30] Comparison of Digital versus Analog 68Ga-PSMA-11 PET/CT Performance in Hormone-Sensitive Prostate Cancer Patients with Early Biochemical Recurrence or Persistence after Radical Treatment
    Rovera, Guido
    Grimaldi, Serena
    Dall'Armellina, Sara
    Zotta, Michela
    Finessi, Monica
    Passera, Roberto
    Deandreis, Desiree
    DIAGNOSTICS, 2023, 13 (23)